니아젠 바이오사이언스 주식회사
DE ˙ DB ˙ US1710774076
€2.70 ↓ -0.30 (-10.00%)
2026-06-04
주가
SecurityDE:OCD1 / Niagen Bioscience, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership43,487 shares
Latest Disclosed Value $ 191,777
Invesco Ltd. reports 0.35% decrease in ownership of OCD1 / Niagen Bioscience, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 43,487 shares of Niagen Bioscience, Inc. (DE:OCD1) valued at $152,204 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 43,641 shares of Niagen Bioscience, Inc.. This represents a change in shares of -0.35% during the quarter. The current value of the position is $117,415 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 43,487 -154 -0.35 192 -31.05 0.0000
2026-02-19 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 43,641 9,688 28.53 278 -12.34 0.0000
2025-11-13 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 33,953 -433,256 -92.73 317 -95.31 0.0000
2025-08-13 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 467,209 100,559 27.43 6,732 166.19 0.0011
2025-05-12 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 366,650 336,422 1,112.95 2,530 1,480.63 0.0005
2025-02-13 2024-12-31 13F CHROMADEX COM NEW 171077407 30,228 -6,481 -17.66 160 20.30 0.0000
2024-11-12 2024-09-30 13F CHROMADEX COM NEW 171077407 36,709 -53,010 -59.08 134 -45.49 0.0000
2024-08-13 2024-06-30 13F CHROMADEX COM NEW 171077407 89,719 89,719 245 0.0001
2022-08-15 2022-06-30 13F CHROMADEX COM NEW 171077407 0 -15,789 -100.00 0 -100.00
2022-05-16 2022-03-31 13F CHROMADEX COM NEW 171077407 15,789 -390 -2.41 39 -36.07 0.0000
2022-02-14 2021-12-31 13F CHROMADEX COM NEW 171077407 16,179 -468 -2.81 61 -41.35 0.0000
2021-11-15 2021-09-30 13F CHROMADEX COM NEW 171077407 16,647 4,094 32.61 104 -16.13 0.0000
2021-08-17 2021-06-30 13F CHROMADEX COM NEW 171077407 12,553 -799,151 -98.45 124 -98.36 0.0000
2021-05-17 2021-03-31 13F CHROMADEX COM NEW 171077407 811,704 811,704 6,366.22 7,582 6,014.52 0.0020
2019-08-14 2019-06-30 13F/A-1 CHROMADEX COM NEW 171077407 0 -67,207 -100.00 0 -100.00
2019-05-15 2019-03-31 13F CHROMADEX COM NEW 171077407 67,207 5,630 9.14 282 33.65 0.0001
2019-02-14 2018-12-31 13F CHROMADEX COM NEW 171077407 61,577 -15,892 -20.51 211 -36.45 0.0001
2018-11-14 2018-09-30 13F CHROMADEX COM NEW 171077407 77,469 17,871 29.99 332 50.23 0.0001
2018-08-14 2018-06-30 13F CHROMADEX COM NEW 171077407 59,598 -112,504 -65.37 221 -69.43 0.0001
2018-05-15 2018-03-31 13F CHROMADEX COM NEW 171077407 172,102 172,102 188.77 723 227.15 0.0003
2017-08-14 2017-06-30 13F CHROMADEX COM NEW 171077407 0 -22,638 -100.00 0 -100.00
2017-05-15 2017-03-31 13F CHROMADEX COM NEW 171077407 22,638 2,865 14.49 61 -6.15 0.0000
2017-02-14 2016-12-31 13F CHROMADEX COM NEW 171077407 19,773 526 2.73 65 14.04 0.0000
2016-11-14 2016-09-30 13F CHROMADEX COM NEW 171077407 19,247 394 2.09 57 -26.92 0.0000
2016-08-15 2016-06-30 13F CHROMADEX COM NEW 171077407 18,853 18,853 78 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.